Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Net Assets
Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has net assets worth CN¥6.22 Billion CNY (≈ $910.32 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥8.20 Billion ≈ $1.20 Billion USD) and total liabilities (CN¥1.98 Billion ≈ $289.84 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Yunnan Botanee Bio-Technology Group Co L to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥6.22 Billion |
| % of Total Assets | 75.85% |
| Annual Growth Rate | 57.06% |
| 5-Year Change | 414.87% |
| 10-Year Change | N/A |
| Growth Volatility | 94.87 |
Yunnan Botanee Bio-Technology Group Co Ltd - Net Assets Trend (2017–2024)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 300957 current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2024)
The table below shows the annual net assets of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2024. For live valuation and market cap data, see Yunnan Botanee Bio-Technology Group Co L (300957) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥6.19 Billion ≈ $905.47 Million |
+2.86% |
| 2023-12-31 | CN¥6.02 Billion ≈ $880.30 Million |
+7.39% |
| 2022-12-31 | CN¥5.60 Billion ≈ $819.72 Million |
+17.23% |
| 2021-12-31 | CN¥4.78 Billion ≈ $699.24 Million |
+297.60% |
| 2020-12-31 | CN¥1.20 Billion ≈ $175.86 Million |
+57.92% |
| 2019-12-31 | CN¥761.02 Million ≈ $111.36 Million |
+68.79% |
| 2018-12-31 | CN¥450.87 Million ≈ $65.98 Million |
+71.80% |
| 2017-12-31 | CN¥262.44 Million ≈ $38.40 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Yunnan Botanee Bio-Technology Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1314.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.74 Billion | 45.30% |
| Common Stock | CN¥423.60 Million | 7.00% |
| Other Comprehensive Income | CN¥229.34 Million | 3.79% |
| Other Components | CN¥2.66 Billion | 43.90% |
| Total Equity | CN¥6.05 Billion | 100.00% |
Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Market Cap
The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Orion Oyj A
HE:ORNAV
|
$2.54 Billion |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
$2.54 Billion |
|
Watsco Inc
NYSE:WSO-B
|
$2.54 Billion |
|
Hinge Health, Inc.
NYSE:HNGE
|
$2.54 Billion |
|
ZhongAn Online P & C Insurance Co. Ltd
F:1ZO
|
$2.53 Billion |
|
China Railway Hi-tech Industry Corp Ltd
SHG:600528
|
$2.53 Billion |
|
Zhongshan Public Utilities Group Co Ltd
SHE:000685
|
$2.53 Billion |
|
Gujarat Mineral Development Corporation Limited
NSE:GMDCLTD
|
$2.53 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Yunnan Botanee Bio-Technology Group Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,860,994,371 to 6,049,901,389, a change of 188,907,018 (3.2%).
- Net income of 503,053,591 contributed positively to equity growth.
- Dividend payments of 262,516,132 reduced retained earnings.
- Share repurchases of 124,879,321 reduced equity.
- Other comprehensive income increased equity by 18,216,211.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥503.05 Million | +8.32% |
| Dividends Paid | CN¥262.52 Million | -4.34% |
| Share Repurchases | CN¥124.88 Million | -2.06% |
| Other Comprehensive Income | CN¥18.22 Million | +0.3% |
| Other Changes | CN¥55.03 Million | +0.91% |
| Total Change | CN¥- | 3.22% |
Book Value vs Market Value Analysis
This analysis compares Yunnan Botanee Bio-Technology Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.83x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 57.95x to 2.83x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥0.71 | CN¥40.88 | x |
| 2018-12-31 | CN¥1.23 | CN¥40.88 | x |
| 2019-12-31 | CN¥1.79 | CN¥40.88 | x |
| 2020-12-31 | CN¥2.83 | CN¥40.88 | x |
| 2021-12-31 | CN¥11.23 | CN¥40.88 | x |
| 2022-12-31 | CN¥13.11 | CN¥40.88 | x |
| 2023-12-31 | CN¥13.86 | CN¥40.88 | x |
| 2024-12-31 | CN¥14.43 | CN¥40.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Yunnan Botanee Bio-Technology Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.32%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.77%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 1.37x
- Recent ROE (8.32%) is below the historical average (34.61%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 60.26% | 19.25% | 1.59x | 1.97x | CN¥128.14 Million |
| 2018 | 58.53% | 21.00% | 1.62x | 1.72x | CN¥216.01 Million |
| 2019 | 54.47% | 21.19% | 1.79x | 1.43x | CN¥336.32 Million |
| 2020 | 45.33% | 20.61% | 1.65x | 1.34x | CN¥423.61 Million |
| 2021 | 18.15% | 21.45% | 0.69x | 1.22x | CN¥387.40 Million |
| 2022 | 18.94% | 20.97% | 0.75x | 1.21x | CN¥496.10 Million |
| 2023 | 12.91% | 13.21% | 0.76x | 1.28x | CN¥170.70 Million |
| 2024 | 8.32% | 8.77% | 0.69x | 1.37x | CN¥-101.94 Million |
Industry Comparison
This section compares Yunnan Botanee Bio-Technology Group Co Ltd's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $946,044,027
- Average return on equity (ROE) among peers: 8.40%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Yunnan Botanee Bio-Technology Group Co Ltd (300957) | CN¥6.22 Billion | 60.26% | 0.32x | $2.53 Billion |
| Lonkey Industrial Co Ltd Guangzhou (000523) | $429.81 Million | 2.53% | 0.50x | $926.62 Million |
| Tianjin Yiyi Hygiene Products Co Ltd (001206) | $161.85 Million | 24.59% | 1.41x | $512.44 Million |
| Hunan Resun Co Ltd (001218) | $310.82 Million | 10.88% | 1.57x | $526.33 Million |
| Qingdao Kingking Applied Chemistry Co Ltd (002094) | $2.87 Billion | 14.06% | 0.63x | $602.56 Million |
| C&S Paper Co Ltd (002511) | $418.43 Million | 12.15% | 2.46x | $1.61 Billion |
| Anhui Deli Household Glass Co Ltd (002571) | $1.47 Billion | -4.17% | 0.37x | $654.99 Million |
| Mingchen Health Co Ltd Class A (002919) | $550.90 Million | 5.38% | 0.27x | $935.25 Million |
| Chongqing Baiya Sanitary Products Co (003006) | $359.21 Million | 16.81% | 0.32x | $1.16 Billion |
| Chengdu Rainbow Appliance Gr (003023) | $1.58 Billion | 6.93% | 0.39x | $467.07 Million |
| Fujian Green Pine Co Ltd (300132) | $1.31 Billion | -5.20% | 0.81x | $713.59 Million |
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. The company operates through Skin Care Products and Medical Instruments segments. It offers face creams, lotions, masks, and essences and lotions; and makeup products, including primers, powders, BB creams, and makeup rem… Read more